Clinical evolution and quality of life of patients with diabetic foot ulcer treated with Heberprot-P®
Keywords:
clinical evolution, diabetic foot, foot ulcer, quality of life, type 2 diabetes mellitusAbstract
Introduction: diabetic foot is a preventable chronic complication that affects the quality of life of patients. The use of Heberprot-P® has a favorable impact on its evolution.
Objective: to describe the evolution of the condition and quality of life in patients with diabetic foot ulcer, treated with Heberprot-P®.
Methods: a cross-sectional descriptive observational study was carried out in a universe of 83 patients from the Fomento health area, who attended the comprehensive diabetic foot care consultation, in the period 2020-2022. Through intentional sampling, a sample of 78 was selected. Sociodemographic, clinical, and quality of life variables were studied using the SF-36 questionnaire. Ethical principles were met.
Results: predominantly female patients, white skin color, and over 65 years of age. All of them had type 2 diabetes. The main treatment consisted of diet, oral hypoglycemic agents, and Heberprot-P® for diabetic foot ulcers. In general, according to patient references, their health-related quality of life was fair.
Conclusions: diabetic foot ulcers treated with Heberprot-P® progressed favorably towards healing. Patients' quality of life (health-related, and measured by physical role, bodily pain, general health, social function, emotional role, and mental health) was described as fair
Downloads
References
Pérez-Díaz Y, Rodríguez-Puga R, Dueñas-Rodríguez Y. Perfil epidemiológico de pacientes atendidos en la consulta de pie diabético. Revista Cubana de Angiología y Cirugía Vascular [revista en Internet]. 2023 [citado 2023 Dic 2]; 24(1):[aprox. 0 p.]. Disponible en: https://revangiologia.sld.cu/index.php/ang/article/view/402
Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2022 [Internet]. La Habana: MINSAP; 2023 [citado 14/11/2023]. Disponible en: https://files.sld.cu/editorhome/files/2023/09/Anuario-Estadistico-de-Salud-2022-Ed-2023.pdf
Pereira N, Suh-Hyunsuk P, Hong-Joon P. Úlceras del pie diabético: importancia del manejo multidisciplinario y salvataje microquirúrgico de la extremidad. Rev Chil Cir [Internet]. 2018 Dic [citado 2023 Dic 02] ; 70( 6 ): 535-543. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S071840262018000600535&lng=es
Lopera-Vásquez JP. Calidad de vida relacionada con la salud: exclusión de la subjetividad. Cien Saude Colet [Internet]. 2020; 25(2):693-702. Disponible en: https://www.scielo.br/j/csc/a/pHhcCB54Xvz7jSZnMg3wbXH/?lang=es
Jay-Cordie B, Sánchez-Hechavarria Z, Kindelán-Mesa LM, Cámbara-Toro Y. Buenas prácticas clínicas con el uso del Heberprot-P® en pacientes con úlcera del pie diabético. Rev Cubana Enfermer [Internet]. 2019 Jun [citado 2023 Dic 02] ; 35( 2 ): e1701. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03192019000200002&lng=es
López-Pérez A, Chiong-Muñoz A, Medina-Artiles A, Álvarez-Valdivia T, Martínez-Rodríguez B, del Pino-Jova L. Calidad de vida relacionada con salud en pacientes con pie diabético con tratamiento de heberprot-P. Acta méd centro [Internet]. 2023 Jun [citado 2023 Dic 02] ; 17( 2 ): 234-246. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2709-79272023000200234&lng=es
Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las
investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil,
octubre 2013. Helsinki: 18ª Asamblea Mundial; 1964 [citado 4 Dic 2023]. Disponible en:
http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf
Fiallo-Cobos R, Gómez-Leyva Be, Díaz-Armas MT. Heberprot-P®: efectividad terapéutica en pacientes con úlcera de pie diabético en Hospital General Docente de Chimborazo, Ecuador. ccm [Internet]. 2020 Mar [citado 2023 Dic 02] ; 24( 1 ): 100-116. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812020000100100&lng=es
Medina-Fuentes G, Carbajales-León EB. Resultados del tratamiento con Heberprot-P® en pacientes con diagnóstico de pie diabético. Rev Cubana Med Gen Integr [Internet]. 2022 Jun [citado 2023 Dic 02] ; 38( 2 ): e1815. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086421252022000200011&lng=es.
Hierrezuelo-Rojas N, Fernández-González P, Girón-Pérez E. Costos y resultados del tratamiento con Heberprot-P® en pacientes con pie diabético del Policlínico “Ramón López Peña”. Rev Cubana Med Gen Integr [Internet]. 2022 Mar [citado 2023 Dic 02] ; 38( 1 ): e1692. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252022000100009&lng=es.
Desten-Ramos A, Ramirez-Moran AF, Grave de Peralta-Randhol S, Wilson-Chibás FM. Heberprot-P® en úlcera del pie diabético. Policlínico Universitario “Emilio Daudinot Bueno”. Gac Méd Espirit [Internet]. 2020 Dic [citado 2023 Dic 02] ; 22( 3 ): 44-53. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S160889212020000300044&lng=es
Martínez-Gálvez I, Rodríguez-Rodríguez Y. Úlcera del pie diabético tratado con Heberprot-p®. Rev Cubana Angiol Cir Vasc [Internet]. 2020 Abr [citado 2023 Dic 02]; 21( 1 ): e90. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S168200372020000100002&lng=es
Ascaño-Ortega AC. Complex lesions in neuroinfectious diabetic foot and its treatment with Heberprot-P®. Rev Cubana Angiol Cir Vasc [Internet]. 2020 Dic [citado 2023 Dic 02] ; 21( 3 ): e187. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372020000300012&lng=es.
Franco-Aguirre JQ, Cardona-Tapias AA, Cardona-Arias JA. Calidad de vida relacionada con la salud en pacientes con artritis reumatoide de MedellinColombia, 2014. Rev Colomb Reumatol [Internet]. 2015 [citado 2/12/2023];22(3):153-161. Disponible en: http://www.scielo.org.co/scielo.php?pid=S012181232015000300003&script=sci_arttext&tlng=es
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jim Alex González Consuegra, Jesús Daniel Roche Toledo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
